Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FP57D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,371
Award facts
- Contract value 100% obligated
- $20,370.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,370.54 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors on August 13, 2025, with completion scheduled for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be sourced from the contractor's corporate office in Conshohocken, Pennsylvania, which serves as the place of performance for this transaction.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), a global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to fulfill federal requirements through open competition, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FP57D?
SPE2DB25FP57D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FP57D worth?
The government has obligated $20,371 on SPE2DB25FP57D.
Is contract SPE2DB25FP57D an order under another contract?
Yes. SPE2DB25FP57D is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP57D competed?
The extent of competition for SPE2DB25FP57D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award